Here's Why Conmed (CNMD) is a Strong Momentum Stock
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Zacks·12d ago
More News
Here's Why You Should Retain CONMED Stock in Your Portfolio for Now
CNMD's growth drivers - AirSeal, Buffalo Filter, BioBrace, and Foot & Ankle - are offsetting tariffs and supply risks, making the stock worth retaining.
Zacks·13d ago
Why Conmed (CNMD) is a Top Value Stock for the Long-Term
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Zacks·15d ago
Here's Why Conmed (CNMD) is a Strong Growth Stock
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Zacks·18d ago
Why Conmed (CNMD) is a Top Momentum Stock for the Long-Term
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Zacks·28d ago
Why Conmed (CNMD) is a Top Growth Stock for the Long-Term
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Zacks·1mo ago
CONMED Q2 Earnings & Revenues Beat Estimates, 2025 Outlook Raised
CNMD reports solid second-quarter results, driven by improving sales across both segments.
Zacks·1mo ago
Compared to Estimates, Conmed (CNMD) Q2 Earnings: A Look at Key Metrics
While the top- and bottom-line numbers for Conmed (CNMD) give a sense of how the business performed in the quarter ended June 2025, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Zacks·1mo ago
Conmed (CNMD) Q2 Earnings and Revenues Top Estimates
Conmed (CNMD) delivered earnings and revenue surprises of +1.77% and +0.81%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·1mo ago
Here's Why You Should Retain CONMED Stock in Your Portfolio for Now
CNMD stock rides high on strong recurring revenues, margin gains, and surgical product growth despite supply and cybersecurity challenges.